Pharmafile Logo

Brian O’Shaughnessy

- PMLiVE

Uniphar and ImmunityBio Partner to Support International Operational Launch and Distribution of ANKTIVA® Across Europe, the UK and MENA

Uniphar and ImmunityBio Partner to Support International Operational Launch and Distribution of ANKTIVA® Across Europe, the UK and MENA   [Dublin, 18th November 2026] Uniphar has today announced a strategic...

Uniphar

keystone banner and screenshot

Genesis Research Group launches Keystone IEGP platform at ISPOR Europe 2026

Genesis Research Group (Genesis) launches Keystone, its modular platform for Integrated Evidence Generation Planning (IEGP), at ISPOR Europe 2026.

Genesis Research Group

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization

Uniphar

The Vector Issue 3 banner

Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...

Genesis Research Group

promo for Tim's discussion of GLOBE Final Rule

On GLOBE Final Rule

The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....

Genesis Research Group

Sarah Alwardt of Genesis Research Group

Genesis Research Group Appoints Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR

Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global real-world evidence...

Genesis Research Group

- PMLiVE

Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients

True "beyond-the-pill" strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.

Impetus Digital

- PMLiVE

Achieving launch excellence through cross-functional collaboration

‘Cross-functional collaboration that’s grounded in a clear evidence roadmap is the foundation for successful, sustainable launches’

Genesis Research Group free access image

Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026

Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers. “Run it...

Genesis Research Group

- PMLiVE

Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

Uniphar

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links